Parkinson’s Disease Related Content

Cell therapy holds promise as a new treatment for Parkinson’s disease, but in many trials to date, most transplanted dopamine cells have failed to survive, raising a fundamental obstacle. Recent advancements led by researchers at McLean Hospital and Massachusetts General Hospital could change this...

In a novel research study conducted by a team from the Neuroregeneration Institute at McLean Hospital, investigators believe they have found key brain cell type changes involving lipids, inflammation, and the development of Parkinson’s disease (PD). Their findings appear in the current issue of the...

A team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) reported that reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) is technically feasible. PD is the second most common...

Investigators have identified two molecules naturally produced by the body that stimulate the production of dopamine, the molecule that is in short supply in the brains of patients with Parkinson’s disease. Stimulating dopamine production may help reverse the progression of the disease. The research...

Reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) in the most recent issue of The...

The National Institutes of Health (NIH) has awarded McLean Hospital’s Neuroregeneration Institute (NRI) a $6 million grant over 5 years to further its groundbreaking research on stem cell-based therapy for Parkinson’s disease (PD). The NIH developed the Cooperative Research to Enable and Advance...

A collaborative team of researchers at McLean Hospital, a Harvard Medical School affiliate, and the University of Oxford has found that elevated levels of certain types of lipids (fat molecules) in the brain may be an early sign of Parkinson’s disease (PD). This finding could have significant...

In the United States alone, as many as one million people have Parkinson’s disease (PD), with approximately 60,000 cases being diagnosed each year, according to the Parkinson’s Disease Foundation. Kwang-Soo Kim, PhD , director of the Molecular Neurobiology Laboratory at McLean Hospital and professor...